HER2-positive breast cancer -a vailable anti-HER2 therapies and new agents under investigation

• Autorzy: Zielinska M. , Zarankiewicz N. , Kosz K. , Kuchnicka A. , Cisel B.
• Języki publikacji: EN

Abstrakty

EN

• Wydawca: -
• Czasopismo: Journal of Pre-Clinical and Clinical Research
• Rocznik: 2020
• Tom: 14
• Numer: 2
• Opis fizyczny: p.44-48,ref.

Twórcy

autor

Zielinska M.

• Students’ Scientific Association, Oncological Surgery Department, Medical University, Lublin, Poland

autor

Zarankiewicz N.

• Students’ Scientific Association, Oncological Surgery Department, Medical University, Lublin, Poland

autor

Kosz K.

• Students’ Scientific Association, Oncological Surgery Department, Medical University, Lublin, Poland

autor

Kuchnicka A.

• Students’ Scientific Association, Oncological Surgery Department, Medical University, Lublin, Poland

autor

Cisel B.

• Oncological Surgery Department, Independent Public Teaching Hospital No. 1, Medical University, Lublin, Poland

Identyfikatory

DOI

10.26444/jpccr/122068